Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Hu

Showing results (1011-1020 of 1,174) with videos related to

Pageof 118
Sort By:
Frontiers in Oncology|October 4, 2021
Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled TrialYu-Chun Song, Guang-Yi Sun, Hui Fang, et al.
JAMA Network Open|December 19, 2019
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical TrialNan Bi, Jun Liang, Zongmei Zhou, et al.
Journal of Medicinal Chemistry|June 29, 2019
Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-<i>N</i>-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal TumorsYun Wu, Beilei Wang, Junjie Wang, et al.
Journal of Medicinal Chemistry|December 15, 2016
Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge BindingQiang Wang, Feiyang Liu, Beilei Wang, et al.
Developmental Cell|August 14, 2025
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasisJie Zheng, Han She, Rui Han, et al.
Protein Science : a Publication of the Protein Society|August 15, 2024
Integrating molecular dynamics simulation with small- and wide-angle X-ray scattering to unravel the flexibility, antigen-blocking, and protease-restoring functions in a hindrance-based pro-antibodyJun Min Liao, Shih-Ting Hong, Yeng-Tseng Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 19, 2024
pH-Responsive β-Glucans-Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer ImmunotherapyPo-Kai Luo, Hui-Min Ho, Min-Chun Chiang, et al.
Frontiers in Immunology|September 30, 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiationLindsey Sloan, Rupashree Sen, Chunnan Liu, et al.
Military Medical Research|October 13, 2022
Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Na<sub>v</sub>1.5 downregulation and ventricular arrhythmiasChen-Chen Hu, Xin Wei, Jin-Min Liu, et al.
Journal of Neurology|December 11, 2023
Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disordersYujie Wang, Chen Hu, Salman Aljarallah, et al.
Pageof 118

Showing results (1011-1020 of 1,174) with videos related to

Sort By:
Pageof 118
Frontiers in Oncology|October 4, 2021
Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled TrialYu-Chun Song, Guang-Yi Sun, Hui Fang, et al.
JAMA Network Open|December 19, 2019
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical TrialNan Bi, Jun Liang, Zongmei Zhou, et al.
Journal of Medicinal Chemistry|June 29, 2019
Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-<i>N</i>-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal TumorsYun Wu, Beilei Wang, Junjie Wang, et al.
Journal of Medicinal Chemistry|December 15, 2016
Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge BindingQiang Wang, Feiyang Liu, Beilei Wang, et al.
Developmental Cell|August 14, 2025
Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasisJie Zheng, Han She, Rui Han, et al.
Protein Science : a Publication of the Protein Society|August 15, 2024
Integrating molecular dynamics simulation with small- and wide-angle X-ray scattering to unravel the flexibility, antigen-blocking, and protease-restoring functions in a hindrance-based pro-antibodyJun Min Liao, Shih-Ting Hong, Yeng-Tseng Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 19, 2024
pH-Responsive β-Glucans-Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer ImmunotherapyPo-Kai Luo, Hui-Min Ho, Min-Chun Chiang, et al.
Frontiers in Immunology|September 30, 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiationLindsey Sloan, Rupashree Sen, Chunnan Liu, et al.
Military Medical Research|October 13, 2022
Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Na<sub>v</sub>1.5 downregulation and ventricular arrhythmiasChen-Chen Hu, Xin Wei, Jin-Min Liu, et al.
Journal of Neurology|December 11, 2023
Expanding clinical profiles and prognostic markers in stiff person syndrome spectrum disordersYujie Wang, Chen Hu, Salman Aljarallah, et al.
Pageof 118